Press releases
- LivaNova to Announce Second-Quarter 2024 Results
- LivaNova Provides Update on RECOVER Clinical Study Evaluating VNS Therapy for Treatment-Resistant Depression in Unipolar Patients
- LivaNova to Present at the Goldman Sachs Healthcare Conference
- LivaNova Reports First-Quarter 2024 Results
- LivaNova Announces Ahmet Tezel, Ph.D., as Chief Innovation Officer
- LivaNova Issues Notice to U.S. Patients Regarding Cybersecurity Incident
More ▼
Key statistics
As of last trade LivaNova PLC (LIA:DUS) traded at 49.00, 3.81% above its post-IPO low of 47.20, set on Jun 12, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 48.80 |
---|---|
High | 49.00 |
Low | 48.80 |
Bid | 49.00 |
Offer | 51.00 |
Previous close | 48.80 |
Average volume | 0.00 |
---|---|
Shares outstanding | 54.15m |
Free float | 53.68m |
P/E (TTM) | -- |
Market cap | 2.89bn USD |
EPS (TTM) | -0.5911 USD |
Data delayed at least 15 minutes, as of Jun 20 2024 11:32 BST.
More ▼